Tumor-targeted Drug Delivery by Nanocomposites

Author(s): Abu Baker, Mohd Salman Khan, Muhammad Zafar Iqbal, Mohd Sajid Khan*

Journal Name: Current Drug Metabolism

Volume 21 , Issue 8 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Background: Tumor-targeted delivery by nanoparticles is a great achievement towards the use of highly effective drug at very low doses. The conventional development of tumor-targeted delivery by nanoparticles is based on enhanced permeability and retention (EPR) effect and endocytosis based on receptor-mediated are very demanding due to the biological and natural complications of tumors as well as the restrictions on the design of the accurate nanoparticle delivery systems.

Methods: Different tumor environment stimuli are responsible for triggered multistage drug delivery systems (MSDDS) for tumor therapy and imaging. Physicochemical properties, such as size, hydrophobicity and potential transform by MSDDS because of the physiological blood circulation different, intracellular tumor environment. This system accomplishes tumor penetration, cellular uptake improved, discharge of drugs on accurate time, and endosomal discharge.

Results: Maximum drug delivery by MSDDS mechanism to target therapeutic cells and also tumor tissues and sub cellular organism. Poorly soluble compounds and bioavailability issues have been faced by pharmaceutical industries, which are resolved by nanoparticle formulation.

Conclusion: In our review, we illustrate different types of triggered moods and stimuli of the tumor environment, which help in smart multistage drug delivery systems by nanoparticles, basically a multi-stimuli sensitive delivery system, and elaborate their function, effects, and diagnosis.

Keywords: Nanoparticles, MSDDS, tumor environment, targeting, EPR, therapeutic, zeta potential.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Page: [599 - 613]
Pages: 15
DOI: 10.2174/1389200221666200520092333
Price: $65

Article Metrics

PDF: 7